New Enterprise Associates (NEA) is a prominent venture capital firm established in 1977, headquartered in Menlo Park, California, with additional offices in the U.S., India, and China. NEA specializes in investing in technology and healthcare sectors, with a focus on enterprise, consumer, fintech, life sciences, and digital health companies. The firm engages with entrepreneurs at various stages of business development, providing support from initial funding to public offerings. NEA invests globally, with a significant presence in Asia, including China and India, as well as the United States. The firm typically invests between $0.05 million and $20 million per deal.
Glacier, founded in 2019 and based in San Francisco, California, has developed the first affordable, high-performing, and space-efficient AI-enabled robot designed specifically for recycling. The company aims to transform the recycling industry by utilizing artificial intelligence-powered sensors and robotics to automate the sorting of recyclable materials. This innovative approach allows recycling facilities to enhance their operational efficiency, improve sorting accuracy, and ultimately increase profitability. By integrating advanced technology into the recycling process, Glacier is positioned to significantly impact how recycling facilities manage and process materials.
Aetherflux
Series A in 2025
Aetherflux is an aerospace company that designs and operates a constellation of small satellites to harvest sunlight in space, convert it into electricity, and wirelessly transmit power to ground stations. This innovative approach aims to provide reliable, renewable energy to households, businesses, and military operations worldwide, reducing environmental impact.
Cambium Carbon
Series A in 2025
Cambium Carbon is an early-stage social enterprise focused on addressing climate change through innovative reforestation and urban wood reuse initiatives. The company collaborates with cities and various public and private partners to salvage fallen city trees that would otherwise end up in landfills. By transforming this wood waste into valuable resources, Cambium Carbon establishes reforestation hubs that create a circular economy for urban forests. These hubs not only generate revenue to support tree planting and maintenance projects but also foster sustainable job creation and contribute to the development of resilient urban environments. Through its efforts, Cambium Carbon aims to implement systems-level natural climate solutions that benefit both the environment and local communities.
Music AI
Series A in 2025
Music AI is a software development company that provides artificial intelligence solutions for music and audio technology.
Ouro Medicines
Series A in 2025
Ouro Medicines is a biotechnology company dedicated to immunology, focusing on treating chronic, immune-mediated illnesses. It specializes in integrating scientific knowledge and clinical trial experience to develop innovative, cell-depleting therapies. The company's core technology involves T cell engager antibodies that target and eliminate specific pathogenic cells, aiming to provide extended remissions for patients without the need for continuous immunosuppression.
Orbis Medicines
Series A in 2025
Orbis Medicines is a company focused on drug discovery, utilizing a unique macrocyclic chemistry and computational platform to develop new therapeutics. By employing high-throughput techniques, Orbis aims to accelerate the drug discovery process, particularly for challenging targets that address significant unmet medical needs. Their innovative approach is designed to enhance the efficiency and effectiveness of developing treatments, ultimately improving patient outcomes.
Backflip AI
Series A in 2024
Backflip AI operates a platform that combines human creativity with 3D generative AI, enabling engineers and designers to work efficiently and produce highly realistic models. These models can be used in various applications, such as 3D printing, video game assets, renders, and digital media, as well as in the design of physical structures like buildings and automobiles. The company's technology aims to accelerate design processes and provide businesses with a competitive edge.
Avenzo
Series A in 2024
Avenzo Therapeutics is a clinical-stage company focused on developing innovative oncology therapies aimed at treating cancer. The company’s platform is dedicated to creating novel treatments specifically for underserved cancers, including rare and genomically defined types. By advancing a pipeline of targeted drug candidates, Avenzo Therapeutics seeks to enhance treatment options for both researchers and patients, addressing significant gaps in current cancer care.
Genmo
Series A in 2024
Genmo is a technology company that develops an artificial intelligence platform for creative content generation. Its platform enables users to create high-quality videos, images, and 3D models using intuitive text and image prompts, leveraging advanced natural language processing technology. This allows video creators to generate custom visual media and produce cinematic video content with the assistance of AI.
Firestorm
Series A in 2024
Firestorm is focused on developing modular open-source architecture tailored to meet the needs of the Department of Defense, emphasizing affordability and mass production. The company specializes in the manufacturing of loitering munitions and mission-adaptable systems designed to enhance aerial weaponry. Its products offer significant modularity and precision in payload delivery, equipping paratroopers with advanced aircraft suitable for modern combat scenarios. By prioritizing low-cost solutions, Firestorm aims to contribute to the evolving demands of the hyper-enabled battlefield.
DeltaStream
Series A in 2024
DeltaStream operates a self-service stream processing platform designed to assist businesses in processing and analyzing streaming data in real time. The platform leverages Apache Flink to provide serverless stream processing, enabling users to build materialized views and conduct real-time analytics without the need for infrastructure management. Key features include data governance, unified views, third-party sharing, private software-as-a-service (SaaS), and query-level scaling. By addressing various streaming analytics and database use cases, DeltaStream offers limitless scalability, allowing organizations to effectively harness the power of their streaming data.
Sakana AI
Series A in 2024
Sakana AI is a research-focused company dedicated to developing innovative foundation models inspired by nature. It specializes in creating an AI model capable of generating text, images, video, code, and multimedia, facilitating collaborative research and development in generative AI. The company's AI development process emphasizes evolution and collective intelligence.
Amber Therapeutics
Series A in 2024
Amber Therapeutics is a biotechnology company that specializes in developing advanced bioelectrical therapies aimed at treating functional disorders of the peripheral nervous system. The company creates a bioelectronic platform that delivers closed-loop bioelectrical treatments, which can sense and adapt to the patient's needs while also providing stimulation. By focusing on conditions such as mixed urinary incontinence, Amber Therapeutics seeks to enhance clinical efficacy and patient outcomes through innovative approaches that emphasize the peripheral nervous system rather than the central nervous system. Its technology has the potential to significantly improve treatment methods and overall patient care in targeted disease areas.
Twelve Labs
Series A in 2024
Twelve Labs specializes in a multimodal artificial intelligence platform designed to enhance video understanding across various applications. The platform enables businesses and developers to analyze video content by integrating visual and auditory data, facilitating the creation of intelligent video applications. It offers APIs for functions such as searching, generating, and classifying video content, allowing users to deploy solutions on any cloud, customize models, and fine-tune with their own data. Twelve Labs serves diverse industries, including technology, media, entertainment, and security, empowering clients to harness complex video information for a range of downstream tasks.
Xaira Therapeutics
Venture Round in 2024
Xaira Therapeutics is an integrated biotechnology company focused on revolutionizing drug discovery and development through the application of artificial intelligence. Headquartered in the San Francisco Bay Area, Xaira combines expertise in machine learning, extensive biological and clinical data generation, and robust therapeutic product development. By harnessing advanced AI techniques, the company aims to enhance the understanding of biological processes and improve the effectiveness of therapies. Xaira's approach encompasses all stages of drug discovery, striving to transform how diseases are treated and enabling clients to deliver innovative therapeutic solutions.
AI Squared
Series A in 2024
AI Squared helps large organizations bring AI to where work happens. We do this by leveraging our SaaS or on-prem platform which combines data sources with advanced AL/ML functionality and embeds intelligent insights into critical business applications. Trusted by the largest financial institutions, the most complicated supply chain logistics companies, and the US Department of Defense, we enable seamless collaboration between data science teams and business users, driving faster, more informed decision-making.
Avenzo
Series A in 2024
Avenzo Therapeutics is a clinical-stage company focused on developing innovative oncology therapies aimed at treating cancer. The company’s platform is dedicated to creating novel treatments specifically for underserved cancers, including rare and genomically defined types. By advancing a pipeline of targeted drug candidates, Avenzo Therapeutics seeks to enhance treatment options for both researchers and patients, addressing significant gaps in current cancer care.
Foundry
Series A in 2024
Foundry is a public cloud supported by an orchestration platform designed to simplify the utilization of AI computing resources. Foundry addresses fundamental economic and technical obstacles encountered in AI and deep learning. Current challenges faced by businesses, such as the notable GPU scarcity and inefficient use of computing capabilities, hinder their effective utilization of resources. Foundry employs pioneering approaches to overcome these hurdles, offering scalable GPU instances with unparalleled price-performance ratios.
Together AI
Series A in 2024
Together AI is a cloud-based platform designed for constructing open-source generative AI and infrastructure for developing AI models. The company contributes cutting-edge open-source research, models, and datasets to push the boundaries of AI forward. Through its decentralized cloud services, developers and researchers at organizations of various scales are empowered to train, refine, and deploy generative AI models.
Mojo Vision
Series A in 2023
Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.
Rocket.Chat
Series A in 2023
Rocket.Chat Holdings, Ltd., established in 2015, specializes in developing and operating an open-source web chat platform. The company offers a comprehensive suite of communication tools, including video conferencing, file sharing, screen sharing, and voice messages, along with API and native mobile applications. Rocket.Chat also provides white-labeling, integrations, and hosting services, catering to over 500,000 servers and 12 million users worldwide. Its platform enables secure, real-time communication, both internally and externally, and can be run on-premises or in the cloud. With an active community of over 1,000 developer-contributors, Rocket.Chat continually improves its product, aiming to replace email with a real-time, federated communications platform and foster a marketplace for app-building and business services.
Nexo Therapeutics
Series A in 2023
Nexo Therapeutics is a biotechnology company focused on developing small-molecule therapies for cancer patients who have few effective treatment options. The company utilizes a specialized platform that integrates covalent ligand discovery with chemical biology to create innovative oncology drugs aimed at challenging targets that have been difficult to address in the past. By advancing its pipeline of novel therapies, Nexo Therapeutics seeks to provide new avenues for treatment, ultimately enhancing the care available to individuals battling cancer and other related diseases.
Tagworks Pharmaceuticals
Series A in 2023
Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands, established in 2011 as a spin-out from Philips Healthcare. The company focuses on developing innovative in vivo chemistry to enhance the effectiveness of cancer therapies and to facilitate novel companion diagnostics. Operating from the Radboud University Medical Center in Nijmegen, Tagworks specializes in antibody-based imaging and therapy technologies. Its proprietary approach allows for the selective chemical manipulation of tagged antibodies in vivo, which improves the efficacy of established methods like radioimmuno-imaging and antibody-drug conjugates. This technology enables medical professionals to conduct imaging with significantly reduced radiation exposure for patients.
Djust
Series A in 2023
DJUST is a provider of a cloud-based B2B platform that facilitates the rapid launch of e-commerce and e-procurement solutions for businesses. The company combines digital showrooms, an e-commerce marketplace, and customer relationship management (CRM) tools into a single integrated product. This streamlined approach allows clients to easily set up and expand their online operations, enhancing their ability to engage in digital commerce effectively. By offering a comprehensive solution, DJUST aims to simplify the process for businesses looking to establish or upgrade their online presence.
Granica
Series A in 2023
Granica provides a data readiness platform designed to support enterprises in effectively leveraging artificial intelligence. The platform enables data engineers and leaders to prepare AI-ready data that enhances the efficiency and safety of AI, machine learning, and analytics initiatives. By optimizing data sets for training and inference, Granica reduces storage costs by up to 60% and improves query performance by up to 56%. The company focuses on ensuring data privacy and mitigating the risks of sensitive data leakage while enhancing the accuracy and fairness of AI models. Granica curates and refines training data sets, selecting impactful samples to boost model performance and instill greater trust in AI applications. Targeting industries such as financial services, retail, geo-spatial intelligence, and autonomous vehicles, Granica aims to make AI implementations more effective and beneficial for its clients.
Union.ai
Series A in 2023
Union.ai is a Kubernetes-native workflow orchestration platform for data and machine learning at scale. Union.ai provides software users with the tools they need to move their ideas from concept to high-quality production. Union's aim is to organize the numerous processes required to train and grow the most sophisticated and dynamic machine learning and data products.
Limitless
Series A in 2023
Rewind is a personalized AI powered by everything you’ve seen, said, or heard.
Kira
Venture Round in 2023
Kira Learning is an AI-driven education technology company that creates innovative tools and solutions to support educators and students. Its primary mission is to empower schools, districts, and teachers by integrating cutting-edge artificial intelligence into educational practices, making teaching more effective and learning more engaging.
Kindred
Series A in 2023
Kindred operates a members-only network for house sharing, distinguishing itself from traditional vacation rental platforms. In this unique model, each participant must host their own home to be eligible to stay in another member's property, fostering a higher level of trust among users. The network is designed for individuals seeking a travel-rich lifestyle without the costs associated with hotels or vacation rentals, as there is no financial exchange between guests and hosts. By facilitating home exchanges among trusted peers rather than professional hosts, Kindred creates a community that promotes affordable travel experiences.
SimpleRose
Venture Round in 2023
SimpleRose Inc. is a technology company based in Saint Louis, Missouri, that specializes in developing a prescriptive analytics platform aimed at enhancing decision-making processes in complex environments. Founded in 2018, the company's solutions focus on optimizing operations through applications such as scheduling, production planning, and portfolio optimization. By leveraging algorithmic innovations for improved numerical accuracy and speed, SimpleRose enables organizations to tackle intricate operational challenges and make informed decisions in real-time.
Perplexity
Series A in 2023
Perplexity is an artificial intelligence-based search engine platform that combines large language models with traditional search engines. It leverages natural language processing and generative AI technologies to deliver conversational responses to user queries, aiming to enhance the search experience beyond standard results. The platform is designed to facilitate the development of safe and beneficial artificial general intelligence, offering an open-source environment accessible to the public. This allows clients to acquire skills and knowledge in software development, positioning Perplexity as a bridge between conventional search capabilities and advanced AI-driven assistance.
OP3N
Series A in 2023
Founded in 2021 as a subsidiary of EST Media Holdings, OP3N is a global Web3 superapp that integrates communication, connection, and commerce within a unified interface, facilitating on-chain interactions. The company aims to foster a more decentralized and democratized creator economy by consolidating essential tools for minting, sharing, and engaging with digital goods and tokens. OP3N's leadership team, which includes media executive Jaeson Ma and development executive Eric Tu, brings extensive experience from the entertainment, gaming, and technology sectors. The company is committed to creating community-driven entertainment experiences and has established partnerships for various projects, including collaborations with Tokyo fashion label AMBUSH, an intergalactic children's book by Grimes, and a musical film with Simon Fuller. OP3N is headquartered in Los Angeles and focuses on empowering artists to directly engage with their fans through token-gated access, all within a Web3 framework.
Flox
Series A in 2023
Flox develops a web application that enhances developer productivity throughout the software development lifecycle. The company offers SaaS products that leverage Nix, allowing enterprises to install packages, manage development and production environments, and ensure consistent software deployment across embedded devices. By enabling developers to treat environments and packages as code, Flox streamlines the process of building and managing software, promoting efficiency and reliability in development practices.
Launchpad Therapeutics
Series A in 2022
Launchpad Therapeutics is an antibody-focused precision oncology company that specializes in developing early mutant-selective antibodies to enhance cancer therapies. Utilizing artificial intelligence-driven programs, the company aims to create novel monoclonal antibodies, facilitating drug design, development, and testing for research purposes. This innovative approach provides medical professionals with new alternatives for cancer treatment, addressing the complexities of the disease through targeted therapeutic strategies.
Fizz
Series A in 2022
Fizz is an authorized platform designed to enhance community social structures, particularly within institutions. It develops online social media software that facilitates communication and the sharing of ideas, events, and experiences among users. The platform allows individuals to post secret confessions and ask questions within a closed community, promoting social interaction while maintaining anonymity. By leveraging these features, Fizz aims to foster a more connected and engaged community environment.
Partiful
Series A in 2022
Partiful is an online platform designed to facilitate the planning and management of social events, including parties and gatherings. The service enables users to create invitations, communicate with guests, and invite friends-of-friends even if their contact information is unavailable. By focusing on the organization of various social events, from intimate dinners to larger parties, Partiful aims to enhance real-world relationships and foster meaningful connections among individuals. The platform provides a streamlined approach to event planning, making it easier for users to cultivate friendships and create memorable experiences.
Bliq
Series A in 2022
Bliq GmbH, founded in 2019 and based in Berlin, Germany, develops application software tailored for rideshare and delivery drivers. The company's flagship product, the "Bliq Ride" app, enables gig workers in the transport sector to streamline their daily operations by allowing them to accept or reject orders from multiple platforms. By leveraging traffic data and crowd-sourced information, Bliq aims to enhance the productivity and efficiency of its users. With a team of 25 employees, the company continues to focus on supporting the needs of the growing gig economy.
PixieBrix
Series A in 2022
PixieBrix is a low-code platform that enables users to customize and automate web tools through a browser extension. It allows for the rapid creation of modifications and integrations, enhancing the online experience by adding functionality and streamlining workflows. Targeting both entrepreneurs and large organizations, PixieBrix offers an enterprise-ready solution that can be tailored to meet specific needs. The platform utilizes AI and automation technologies to optimize productivity, ensuring seamless integration with any website for quick implementation and immediate results.
QuoteWell
Series A in 2022
QuoteWell is a digital platform specifically designed for the insurance industry, founded in 2021 and headquartered in Austin, Texas. The company provides a data-driven solution that streamlines the submission process for insurance applications, allowing agents and brokers to efficiently transmit applications to various commercial lines underwriters. By facilitating secure data transfers to multiple carriers, QuoteWell enables users to access a modern risk transfer infrastructure and manage their book of business more effectively.
Arkestro
Series A in 2022
Arkestro is a provider of predictive procurement software that enables businesses to enhance savings and improve supply chain performance by integrating preferred outcomes into their processes. The cloud-based platform utilizes artificial intelligence to automate negotiations, facilitating faster decision-making and real-time collaboration. By leveraging instant forecasts, Arkestro allows organizations to achieve savings more efficiently, often 2–5 times faster than traditional methods. This software not only optimizes procurement strategies but also increases vendor participation, helping businesses secure significant savings on managed services and raw materials.
Code Biotherapeutics
Series A in 2022
Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. Code Bio leverages its novel multivalent synthetic DNA delivery platform, 3DNA, which has been engineered to overcome many of the challenges inherent with viral-based gene therapies such as immunogenicity, size and delivery limitations, re-dosability, and manufacturing complexity. The company is advancing an internal pipeline focused on select rare disease programs as well as establishing partnerships to take forward programs in both rare and prevalent diseases.
Bliq
Series A in 2022
Bliq GmbH, founded in 2019 and based in Berlin, Germany, develops application software tailored for rideshare and delivery drivers. The company's flagship product, the "Bliq Ride" app, enables gig workers in the transport sector to streamline their daily operations by allowing them to accept or reject orders from multiple platforms. By leveraging traffic data and crowd-sourced information, Bliq aims to enhance the productivity and efficiency of its users. With a team of 25 employees, the company continues to focus on supporting the needs of the growing gig economy.
Jomboy Media
Series A in 2022
Jomboy Media is an online media production company that specializes in sports and pop culture content. The company creates and distributes original programming across various formats, including podcasts, digital series, and television shows. Jomboy Media emphasizes topics that resonate with its audience, such as sports, movies, music, and history, fostering an engaging environment for both creators and viewers. By enabling content creators to produce their own shows, Jomboy Media cultivates a diverse range of programming that reflects its passion for these subjects.
Wheelhouse
Series A in 2022
Wheelhouse, Inc. is a software company based in San Francisco, founded in 2014, that specializes in revenue management solutions for the short-term rental industry. Its platform assists property owners in determining optimal pricing for their rentals by analyzing local home-sharing listings, hotel rates, and significant market events. The software employs a data-driven pricing algorithm that enables users to optimize revenue and bookings, allowing them to adjust rates based on factors such as seasonality and last-minute discounts. Wheelhouse aims to empower hosts and property owners to maximize their earnings by providing them with the tools and insights necessary for effective pricing strategies.
Nodar
Series A in 2022
NODAR, Inc. is a Boston-based company that specializes in manufacturing advanced sensors for various transportation modes, including cars, trucks, drones, ships, trains, and aircraft. Established in 2018, NODAR focuses on developing cutting-edge camera-based 3D vision systems aimed at enhancing the safety and reliability of autonomous vehicles. Their flagship product, Hammerhead, utilizes off-the-shelf cameras to deliver long-range, ultra-precise depth sensing essential for Level 3 and Level 4 autonomous applications. This technology enables critical functionalities such as collision warning, path planning, and automatic emergency braking, while ensuring cost-effectiveness and high performance. NODAR's innovations target automotive, marine, and railway industries, providing solutions that meet the growing demand for reliable 3D sensing technology in the mainstream automotive market.
Evernow
Series A in 2022
Evernow is a provider of women's health care services focused on supporting women before, during, and after menopause. The company offers an online teleconsultation platform that connects users with specialized doctors and provides access to science-backed information and treatments. Through this platform, Evernow facilitates conversations about effective care for managing changing hormones, empowering women to lead longer and healthier lives.
Antimatter
Series A in 2022
Antimatter is a company that provides cryptographic infrastructure services aimed at enhancing data security for B2B SaaS businesses. Founded in 2021 and located in Oakland, California, Antimatter's technology utilizes secure enclaves found in major cloud platforms to transparently encrypt customer data. This approach allows clients to adhere to stringent data security and privacy standards without necessitating any modifications to their existing code. By addressing the critical challenges of data security, Antimatter offers a solution that streamlines the protection of sensitive information for its customers.
Clockwork Systems
Series A in 2022
Clockwork Systems specializes in technology that enhances time-sensitive applications across on-premises data centers, public clouds, and hybrid environments. The company develops cloud management synchronization solutions that deliver ultra-accurate and scalable time services. By assessing network latency, Clockwork Systems optimizes application performance, enabling businesses to carry out critical functions like precise timestamping and the sequential execution of trades. This technology addresses fundamental latency issues, ultimately increasing productivity for enterprises that rely on accurate timing for their operations.
SafeBase
Series A in 2022
SafeBase, Inc. is a San Francisco-based company founded in 2020 that specializes in cloud-based security software aimed at helping organizations establish and enhance their security programs. The company’s offerings include a smart trust center platform that facilitates the sharing of security posture and automates access to sensitive documents. SafeBase provides solutions such as SafeBase Inspected, which features a website badge linking to a custom security status page, as well as custom security checklists and continuous monitoring of security systems. Additionally, the software assists organizations in configuring security policies, thereby enabling them to implement robust security practices effectively.
Weaviate
Series A in 2022
Weaviate is a developer of an open-source AI platform that specializes in creating search and recommendation systems. The company's hybrid SaaS platform features a powerful AI vector search engine, which is designed to handle various use cases, including semantic search. It also includes plugins for integration into different applications and a user-friendly console for data management. Weaviate's architecture allows for efficient scaling, supporting the deployment of machine learning models and handling billions of data objects. This capability enables clients to leverage advanced search functionalities and enhance their applications with effective recommendation systems.
Splice Bio
Series A in 2022
Splice Bio is a biotechnology company based in Barcelona, Spain, focused on developing innovative gene therapies using its proprietary intein platform technology. Founded in 2012 and originally named Proteodesign, S.L., the company aims to address the needs of patients suffering from incurable genetic diseases. The intein platform, developed from research in the Muir Lab at Princeton University, seeks to overcome two significant limitations of traditional adeno-associated virus (AAV) therapies: it enhances the capacity for larger gene delivery and broadens the range of tissues that can be targeted for treatment.
FTX US Derivatives
Series A in 2022
FTX US is a bitcoin options exchange designed to assist both individual traders and institutions in trading. FTX US allows users to trade a variety of digital assets like Bitcoin, Ethereum, Solana, and Dogecoin. The company was founded by Sam Bankman-Fried and Gary Wang in 2020 and is based in San Francisco, California.
Waymark
Series A in 2022
Waymark is a company focused on enhancing access to and the quality of healthcare for individuals receiving Medicaid. It offers community-based healthcare services designed to improve health outcomes for Medicaid beneficiaries. The company collaborates with primary care providers and equips community care teams with essential resources, including health plans, insulin education, and training. Through these efforts, Waymark aims to support patients in effectively managing their health and navigating the healthcare system.
Sorriso Pharmaceuticals
Series A in 2021
Sorriso Pharmaceuticals is a biotechnology company based in San Diego, California, founded in 2020. The company focuses on developing disease-modifying antibodies aimed at treating inflammatory diseases such as Crohn's disease and ulcerative colitis. Sorriso's innovative platform produces potent antibodies that can be delivered orally, ensuring they remain effective throughout the intestinal system. This approach aims to provide clinical benefits comparable to traditional injectable antibody therapeutics, thereby alleviating the treatment burden for patients who typically rely on injections for their care. By advancing its pipeline of oral therapies, Sorriso Pharmaceuticals seeks to improve patient outcomes and enhance the management of inflammatory diseases.
Belong Health
Series A in 2021
Belong Health is a health insurance company focused on delivering Medicare Advantage and special needs plan products. The company collaborates with local health plans to provide regionally informed and compassionate care to a growing community. By partnering with these regional health plans, Belong Health aims to create a straightforward Medicare experience for eligible members, facilitating access to quality healthcare through trusted insurance partners. This approach allows Belong Health to launch or enhance market-leading plans that address the specific needs of its members.
Wonder
Series A in 2021
Wonder is a technology company that specializes in gaming and food delivery services. It offers an all-in-one gaming platform for Android mobile devices, enabling users to play, stream, and share games across various devices. Additionally, Wonder operates a food delivery service using trucks that function as mobile restaurants. Customers order food through a mobile app, and the Wonder trucks drive to a location near the user's home to prepare and deliver fresh meals on-site.
Tune Therapeutics
Series A in 2021
Tune Therapeutics is focused on developing innovative cell and gene therapies that utilize epigenetic programming to address serious diseases. By harnessing the epigenome, the company aims to create new pathways for treatment without making changes to the DNA sequence itself. This approach allows for the potential development of therapies for complex and widespread medical conditions, positioning Tune Therapeutics at the forefront of advancements in the field of epigenetics.
AviadoBio
Series A in 2021
AviadoBio is focused on developing innovative gene therapies aimed at transforming the lives of individuals affected by neurodegenerative disorders, specifically frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company leverages advanced research from King's College London and the UK Dementia Research Institute to create its therapeutic platform. By integrating a comprehensive understanding of brain biology with proprietary gene therapy techniques, AviadoBio seeks to address the challenges of effectively delivering treatments to targeted areas in the brain. This approach aims to enhance the therapeutic potential of gene therapies, offering hope for halting or potentially reversing the progression of these debilitating diseases.
Prelay
Series A in 2021
Prelay is a developer of a team selling platform that addresses the challenges revenue teams face in coordinating and communicating with internal stakeholders during the sales process. By consolidating deal management within a single, purpose-built platform, Prelay facilitates organized collaboration, reducing reliance on multiple disjointed tools. This integrated approach not only minimizes complications for sales representatives but also provides leaders in sales, presales, and revenue operations with valuable insights into resource effectiveness and goal achievement. The platform streamlines processes and fosters team alignment, enabling clients to close deals more efficiently and accelerate sales. Prelay is supported by prominent investors, including Y Combinator and executives from leading technology companies.
Recludix Pharma
Series A in 2021
Recludix Pharma is a biotechnology company focused on drug discovery, specifically targeting the development of potent and selective inhibitors for challenging protein targets associated with cancer and autoimmune diseases. The company utilizes a unique platform that combines custom-generated DNA-encoded libraries with massively parallel structure-activity relationship determination and proprietary screening tools. This integrated approach aims to enhance the identification and development of novel small molecule medicines, enabling healthcare professionals to create precision therapies that effectively address specific protein targets in these complex diseases.
Datafold
Series A in 2021
Datafold Inc., founded in 2020 and based in San Francisco, California, specializes in solutions for quality assurance and monitoring of analytical data. The company provides tools that automate data quality management, helping organizations extract greater value from their analytical datasets. Key offerings include the ability to compare tables, validate ETL code changes, and automate data quality assurance processes. By simplifying data quality monitoring and enabling instant table comparison and profiling, Datafold enhances data engineering workflows, allowing businesses to maintain high standards of data integrity and reliability.
Merge
Series A in 2021
Merge provides a comprehensive platform for B2B companies to streamline their integration processes through a single application programming interface (API). Founded in 2020, the company specializes in offering Unified APIs that facilitate secure data access across various software categories, such as human resources, accounting, customer relationship management, and file storage. Merge manages the complete integration lifecycle, from a swift initial setup to ongoing maintenance and observability tools, ensuring customer satisfaction. Its services help businesses enhance their operational efficiency by reducing customer churn, accelerating product development, and lowering engineering costs. Based in San Francisco, New York City, and Berlin, Merge has garnered significant support, receiving $75 million in funding from notable investors.
Candy
Series A in 2021
Candy Digital is a rapidly growing company specializing in the creation and distribution of officially licensed non-fungible tokens (NFTs) and digital collectibles. Founded in 2021 by a group including Fanatics, Michael Rubin, Mike Novogratz, and Gary Vaynerchuk, Candy Digital aims to engage fans by providing authentic digital assets that connect them with their interests in sports, art, entertainment, and music. The company operates an NFT ecosystem platform that allows users to purchase, trade, and share these collectibles, ensuring a secure and scalable experience. Under the leadership of CEO Scott Lawin, Candy collaborates with athletes, artists, and content owners to produce unique digital offerings, enhancing the way fans interact with their passions through innovative digital assets.
Wizard
Series A in 2021
Wizard is a New York-based commerce technology startup founded in 2021 that focuses on transforming e-commerce through conversational artificial intelligence (AI). The company develops software solutions that enable brands to sell and market their products directly via text messaging. This innovative approach allows clients to engage customers more effectively, resulting in higher conversion rates compared to traditional e-commerce methods.
Slope.io
Series A in 2021
Slope.io, Inc. is a Mobile, Alabama-based company that specializes in clinical trial logistics, catering to sponsors, contract research organizations (CROs), and research sites throughout the United States. Founded in 2016, Slope.io provides a platform that streamlines the operational processes of clinical trials by translating logistical requirements into structured schedules and workflows. The company offers customized supply kits, known as Slope.io Kitting, tailored to specific sites, patients, or study time points. By connecting clinical trials to their supply chains, Slope.io effectively manages the complexity of delivering devices, drugs, and kits from suppliers to research sites and patients, ensuring real-time coordination and complete traceability.
Neural Magic
Series A in 2021
Neural Magic provides enterprise inference solutions that enhance the performance of open-source large language models across diverse infrastructures. The company's software serves to accelerate artificial intelligence workloads on standard hardware, allowing organizations to efficiently utilize their existing resources. By leveraging big data and deep learning, Neural Magic's technology supports applications such as recommendations, image recognition, and object detection. This enables businesses to overcome the constraints typically associated with traditional hardware accelerators, facilitating secure and cost-effective deployments of AI models.
858 Therapeutics
Series A in 2021
858 Therapeutics is a biotechnology company dedicated to the discovery of small molecule therapeutics aimed at treating cancers and other diseases, particularly those resistant to existing therapies. The company employs innovative strategies in areas such as synthetic lethality, innate immunity, and RNA modulation to develop its therapeutic candidates. Its lead program focuses on a PARG inhibitor, which is currently in early clinical development. By leveraging its platform to investigate the role of RNA modifying proteins in disease biology, 858 Therapeutics is generating a pipeline of targeted small molecules that address critical unmet medical needs in oncology and immunology.
Workera
Series A in 2021
Workera is a precision upskilling platform that enables enterprises, governments, and individuals to enhance their technological capabilities in areas such as data science, machine learning, and artificial intelligence. The platform utilizes artificial intelligence to offer a detailed assessment of workforce skills, providing hyper-personalized learning plans tailored to individual needs. This approach helps organizations identify skill gaps and mobilize talent effectively, ensuring they remain competitive in a rapidly evolving landscape. Through AI-driven mentorship and adaptive assessments, Workera delivers measurable results that facilitate upskilling and reskilling efforts, ultimately supporting informed decision-making in talent acquisition and development.
Vori Health
Series A in 2021
Vori Health is a healthcare provider focused on treating musculoskeletal conditions through an integrated care delivery model. Founded in 2020 and headquartered in New York, the organization offers a comprehensive range of services, including physical therapy, medical assessments, lab and imaging orders, health coaching, and nutritional guidance. Vori Health employs a virtual-first approach to connect patients with a collaborative care team, consisting of board-certified physical medicine physicians, health coach navigators, and physical therapists. This model aims to facilitate effective management of back, neck, and joint issues, guiding patients toward optimal wellness and recovery. By combining evidence-based practices with personalized support, Vori Health strives to improve patient outcomes in musculoskeletal care.
Stablix
Series A in 2021
Stablix Therapeutics is a biotechnology company specializing in Targeted Protein Stabilization (TPS). The company has developed a platform that produces heterobifunctional small molecules, known as RESTORACS, which selectively recruit deubiquitinase enzymes to remove ubiquitin from targeted proteins. This process enhances the stability and activity of these proteins. Stablix focuses on utilizing its innovative technology to create therapeutic programs aimed at treating rare diseases, cancer, and immunological disorders. By restoring protein function, Stablix aims to provide more effective treatment options for complex medical conditions.
Vori Health
Series A in 2021
Vori Health is a healthcare provider focused on treating musculoskeletal conditions through an integrated care delivery model. Founded in 2020 and headquartered in New York, the organization offers a comprehensive range of services, including physical therapy, medical assessments, lab and imaging orders, health coaching, and nutritional guidance. Vori Health employs a virtual-first approach to connect patients with a collaborative care team, consisting of board-certified physical medicine physicians, health coach navigators, and physical therapists. This model aims to facilitate effective management of back, neck, and joint issues, guiding patients toward optimal wellness and recovery. By combining evidence-based practices with personalized support, Vori Health strives to improve patient outcomes in musculoskeletal care.
Rapid Robotics
Series A in 2021
Rapid Robotics, Inc. is a manufacturer of automated cell robots based in San Francisco, California, established in 2019. The company focuses on providing robotic solutions for manufacturers facing labor shortages and the complexities of material handling. Its AI-driven, vision-based platform is designed to handle a variety of palletizing tasks, allowing for rapid deployment of robotic workcells that can adapt to changing business needs. By offering a Robotics-as-a-Service (RaaS) model, Rapid Robotics enables companies to enhance their operational capacity and predictability without the financial burden and complexities associated with traditional robotic ownership and maintenance. The company's technology can be implemented quickly, often within hours, and at a significantly lower cost compared to other automation systems, ultimately improving production margins through increased efficiency and quality.
Goody
Series A in 2021
Goody is a corporate gifting platform that simplifies the process of sending gifts by eliminating the need for recipient addresses. The company offers a diverse selection of curated gifts, ranging from robes and cookies to succulents and spa treatments. This approach allows givers to choose presents without worrying about sizes, as recipients can select their preferred size or swap their gift for another of equal value. Goody's payment system is designed to charge only after the gift has been received, enhancing the experience for both senders and recipients.
Theorycraft Games
Series A in 2021
Theorycraft Games operates as an independent game development studio that operates remotely. The company is in process of developing its first game codenamed Loki. Theorycraft was founded in 2020 and is headquartered in Los Angeles, California, United States.
Rocket.Chat
Series A in 2021
Rocket.Chat Holdings, Ltd., established in 2015, specializes in developing and operating an open-source web chat platform. The company offers a comprehensive suite of communication tools, including video conferencing, file sharing, screen sharing, and voice messages, along with API and native mobile applications. Rocket.Chat also provides white-labeling, integrations, and hosting services, catering to over 500,000 servers and 12 million users worldwide. Its platform enables secure, real-time communication, both internally and externally, and can be run on-premises or in the cloud. With an active community of over 1,000 developer-contributors, Rocket.Chat continually improves its product, aiming to replace email with a real-time, federated communications platform and foster a marketplace for app-building and business services.
Narmi
Series A in 2021
Narmi Inc. is a technology company based in New York that specializes in developing online and mobile banking applications for financial institutions across the United States. Founded in 2016, Narmi focuses on providing regional and community banks and credit unions with a platform that streamlines account opening processes, allowing clients to complete this in under 2.5 minutes. The company’s offerings include features such as fraud protection, multi-factor authentication, and transaction monitoring, which help enhance security and user experience. In addition to banking applications, Narmi also provides website design, development, and hosting services, as well as content generation and management solutions. Their goal is to enable financial institutions to attract, engage, and retain customers through an intuitive, omnichannel banking experience.
New Wave Foods
Series A in 2021
New Wave Foods, Inc., established in 2015 and headquartered in San Francisco, specializes in producing and selling plant-based seafood products. The company offers a range of shrimp alternatives, including sautéed, grilled, breaded, and fried options, as well as shrimp tacos and salads. These products are made from sustainably sourced seaweed, soy protein, and natural flavors, providing a sustainable and healthier alternative to traditional seafood. New Wave Foods serves customers in the culinary market across the United States, positioning itself as a leader in sustainable seafood.
Polyneuron Pharmaceuticals
Series A in 2020
Polyneuron Pharmaceuticals AG is a biotechnology company based in Basel, Switzerland, founded in 2014. The company focuses on developing innovative therapeutics for antibody-mediated autoimmune disorders, particularly those affecting the peripheral nervous system. Its lead candidates include PN-1007 for anti-MAG neuropathy, PN-1018 for multifocal motor neuropathy, and PN-032 and PN-056 for ABO-incompatible transplantation. Polyneuron employs a unique platform technology called Antibody-Catch, which utilizes biodegradable glycopolymers to selectively target and eliminate pathogenic autoantibodies while preserving the overall integrity of the immune system. This approach aims to provide safe and effective treatment options for patients suffering from these complex immune disorders.
Korro Bio
Series A in 2020
Korro Bio Inc., established in 2018 and headquartered in Cambridge, Massachusetts, specializes in developing nucleic acid-based therapeutics targeting specific sequences in genetic code to treat rare diseases. The company's proprietary platform enables efficient and selective RNA editing, leveraging natural processes common to all multicellular organisms. Korro Bio aims to advance this technology to effect changes in protein structure and function across multiple tissues, expanding the reach of genetic medicines with additional precision and tunability by editing RNA instead of DNA.
GRID
Series A in 2020
GRID is a productivity tool that transforms everyday Excel spreadsheets into modern web applications, allowing users to create interactive web documents without requiring new skills. This platform offers an editor that automates the conversion process, enabling users to generate visually appealing and interactive web reports from their spreadsheets. Additionally, GRID facilitates secure sharing and analysis of these documents, empowering clients to turn traditional spreadsheets into dynamic dashboards or applications that enhance collaboration and usability.
MBX Biosciences
Series A in 2020
MBX Biosciences, Inc. is a biotechnology company based in Carmel, Indiana, specializing in the development of therapeutics for rare endocrine disorders. Established in 2018, the company focuses on creating peptides aimed at treating genetic diseases that affect glandular hormones, which play a crucial role in the body’s chemical messaging system. By targeting conditions with inadequate treatment options, MBX Biosciences is dedicated to discovering, developing, and commercializing innovative endocrine therapeutics.
Monte Rosa Therapeutics
Series A in 2020
Monte Rosa Therapeutics is a biotechnology company focused on developing innovative cancer therapeutics that utilize molecular glue degraders (MGDs) to modulate protein degradation pathways. By leveraging the body's natural mechanisms for protein destruction, these small molecule drugs selectively target and degrade disease-causing proteins. The company employs its QuEEN platform, which combines artificial intelligence and proprietary experimental tools, to identify relevant proteins for degradation. With a diverse library of over 50,000 MGD molecules, Monte Rosa's lead candidate, MRT-2359, specifically targets the translation termination factor protein GSPT1, showing promise for treating MYC-driven tumors. The company aims to advance its pipeline of pioneering therapies for cancer and other diseases.
Beyond Identity
Series A in 2020
Beyond Identity, Inc. offers a cloud-native passwordless identity management platform that enhances secure authentication by replacing traditional passwords with X.509-based certificates. Founded in 2019 and based in New York, the company provides a comprehensive suite of features including frictionless login, biometric authentication, and Single Sign-On (SSO) integration for various users such as employees, contractors, and suppliers. Its innovative approach utilizes asymmetric-key cryptography to create a robust Chain of Trust, which incorporates user and device identities along with real-time security posture assessments for adaptive risk-based authentication. This technology not only improves security by eliminating credential-stuffing attacks but also facilitates increased business agility and efficiency, allowing organizations to adopt new business models and significantly reduce operational costs while achieving complete passwordless identity management.
Vimaan
Series A in 2020
Vimaan is a computer vision and AI solution company focused on enhancing inventory management in warehouses. By automating and digitizing inventory tasks, Vimaan addresses the challenges associated with maintaining accurate stock levels. Their suite of products includes solutions for various applications, such as dock tracking, storage management, and order picking. These tools are designed to support warehousing and logistics companies, ultimately enabling clients to improve the efficiency of their supply chains. Vimaan aims to streamline processes from receiving and storing items to order fulfillment and shipping, thus facilitating better inventory control in a range of industries.
Affinia Therapeutics
Series A in 2020
Affinia Therapeutics Inc. is focused on developing gene therapies for various diseases, particularly those affecting the muscles and central nervous system. The company specializes in creating adeno-associated virus (AAV) vectors, leveraging advanced techniques in synthetic and systems biology, as well as high-throughput screening and tissue and single-cell resolution. Founded in 2019 and based in Waltham, Massachusetts, Affinia aims to address significant unmet medical needs by providing rationally designed gene therapies with improved properties. The company's innovative approach seeks to offer effective treatments for devastating conditions that currently lack adequate therapeutic options.
ClearMetal
Series A in 2020
ClearMetal, Inc., based in San Francisco, California, specializes in artificial intelligence software for supply chain operations, focusing on transport and supply chain visibility solutions. Founded in 2014 by experts from Stanford University and leading technology companies, ClearMetal's platform leverages machine learning algorithms to enhance the accuracy and quality of ocean freight data. This cloud-based application consolidates and processes information from multiple sources, providing real-time insights into shipment status and enabling organizations to predict arrival times and manage exceptions effectively. By facilitating access to reliable data, ClearMetal aims to improve logistics efficiency and enhance customer experiences in supply chain management.
Dandelion Energy
Series A in 2020
Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.
Lily AI
Series A in 2020
Lily AI is a developer of an e-commerce product discovery platform that enhances the sales capabilities of brands and retailers. The platform integrates customer-centric product attributes into various components of the e-commerce ecosystem, including site search engines, recommendation systems, and SEO/SEM functionalities. By improving on-site search and personalized product discovery, Lily AI supports retailers in the fashion, home, and beauty sectors, leading to significant increases in traffic, conversion rates, revenue, and brand loyalty. Headquartered in Mountain View, California, the company is backed by venture capital.
Anyscale
Series A in 2019
Anyscale, Inc. is a technology company based in Berkeley, California, founded by the creators of the open-source project Ray. It specializes in developing distributed programming platforms and tools that simplify the creation and scaling of artificial intelligence applications. Anyscale's software enables developers and machine learning engineers to effortlessly scale their applications from local environments to the cloud, eliminating the need for complex infrastructure. The company's framework allows users of varying skill levels to build and deploy compute-intensive applications efficiently, facilitating faster and more cost-effective market entry for AI products. Anyscale aims to enhance the end-to-end AI lifecycle, making it accessible for organizations to leverage AI technologies.
Shape Therapeutics
Series A in 2019
Shape Therapeutics, Inc. is a biotechnology company founded in 2018 and based in Seattle, Washington. The company specializes in RNA-editing gene therapy targeting neurodegenerative disorders, oncology, metabolic conditions, and rare genetic diseases. Its proprietary RNAfix technology enables precise editing of RNA using the body's natural cellular mechanisms, which minimizes risks associated with immunogenicity, cellular toxicity, and off-target DNA editing. Shape Therapeutics employs a comprehensive approach to RNA gene therapy, integrating innovative payload, delivery, and manufacturing platform technologies. This strategy aims to facilitate the development of effective treatments and potential cures for a wide range of diseases, with the goal of enhancing patient outcomes across the healthcare landscape.
The Yes
Series A in 2019
The Yes is an artificial intelligence-based shopping platform founded in 2018 and headquartered in Burlingame, California, with additional operations in New York City. The company aims to transform the e-commerce landscape by leveraging AI technology to enhance the online shopping experience. By focusing on innovative solutions, The Yes seeks to attract critical thinkers who can contribute to reimagining the rules of online retail. The platform is dedicated to creating a dynamic and engaging shopping environment for users.
Aquabyte
Series A in 2019
Aquabyte, Inc. specializes in developing advanced monitoring systems for the fish farming industry, employing computer vision and machine learning technologies. Founded in 2017 and headquartered in San Francisco, California, with an office in Bergen, Norway, Aquabyte's smart camera system enables real-time applications such as detecting biomass, counting sea lice, and monitoring fish appetite. The accompanying web dashboard provides continuous metrics to enhance operational efficiency. By integrating these technologies, Aquabyte aims to reduce operational costs and fish mortality while promoting sustainability in aquaculture. The company’s innovative approach seeks to address the challenges faced by fish farms, ultimately contributing to a more efficient and environmentally friendly industry.
Block Renovation
Series A in 2019
Block Renovation is a home renovation platform that integrates design, construction labor, and materials to create a seamless renovation experience for homeowners and contractors. Founded by Koda Wang and Luke Sherwin, the company aims to simplify the often complex and confusing process of home renovations. By bringing design, sourcing, and project management together, Block Renovation provides homeowners with clarity on outcomes, quality, pricing, and timelines. This approach not only enhances the experience for homeowners looking to improve their living spaces but also offers a more efficient working method for contractors.
Level
Series A in 2019
Level, operating under the name Zero Financial, Inc., is a financial technology company based in San Francisco, California, that offers a modern mobile banking experience. The company's primary products include a mobile banking application, a debit card known as Zerocard, and a checking account called Zero Checking. The app provides users with real-time insights into their finances, displaying debit card purchases alongside other transactions to help manage their budgets effectively. Unlike traditional banking options, Zerocard combines the convenience of a debit card with the benefits of a credit card, offering users unlimited cash back rewards ranging from 1.0% to 3.0% on expenditures, as well as competitive annual interest rates on account balances. Level aims to eliminate common banking fees, striving to simplify personal finance management for its users.
Reneo Pharmaceuticals
Series A in 2019
Reneo Pharmaceuticals is a clinical-stage pharmaceutical company based in San Diego, California, that focuses on developing therapies for patients with rare genetic mitochondrial diseases. These conditions are linked to defects in energy metabolism, leading to issues such as muscle weakness and wasting. The company is developing REN001, an oral drug designed to modulate genes involved in mitochondrial function, aiming to enhance adenosine triphosphate (ATP) production, which is essential for cellular energy. By improving mitochondrial activity, Reneo seeks to enhance the daily functioning and quality of life for patients suffering from these disorders. Founded in 2014, Reneo Pharmaceuticals is committed to addressing the needs of individuals with orphan metabolic diseases.
ARRIS
Series A in 2019
ARRIS specializes in additive molding technology for creating advanced performance composites tailored for mass-market applications such as aerospace, automotive, and consumer products. The company’s innovative manufacturing process focuses on the precise alignment of continuous carbon fibers, allowing for the integration of electronic components and multifunctional materials into a single, topologically optimized part. This technology enables clients to leverage high-performance composites, enhancing the capabilities and efficiency of their products while meeting the demands of modern manufacturing.
Spyglass Ophthalmics
Series A in 2019
Spyglass Ophthalmics, Inc. is a company focused on developing ophthalmic therapeutic devices aimed at enhancing vision and eye care for patients. Founded in 2019 and based in Mission Viejo, California, Spyglass addresses unmet needs in areas such as cataract treatment, lens replacement, and other chronic ophthalmic conditions. By creating innovative devices, the company seeks to provide patients with quality eye treatment that is also affordable.
AppSheet
Series A in 2019
AppSheet is a no-code platform that empowers business users to create powerful applications without the need for programming knowledge. Founded in 2014 and based in Seattle, WA, it allows users to connect with various data sources, including spreadsheets, relational databases, and cloud services. The platform facilitates the rapid development of customizable applications that can incorporate features such as offline access, workflow automation, and machine learning capabilities. These applications are designed to function across multiple platforms, including web, iOS, Android, and messaging services. AppSheet's focus on user-friendly app creation enables organizations to leverage their data effectively while adhering to IT governance and security standards.
Metabase
Series A in 2019
Metabase is an open-source analytics and business intelligence application founded in 2014 and based in San Francisco, California. The platform enables users to create dashboards and reports, facilitating the measurement, analysis, and sharing of data to address complex business challenges. Metabase offers various professional services, including managed hosting and support, as well as assistance with implementing customized analytics solutions. This enables organizations to track data trends over time, enhancing their decision-making processes.
The Well
Series A in 2019
THE WELL is a membership-based wellness club and spa located in New York City, catering to busy urban professionals. The organization integrates both Western medicine and Eastern healing practices to create a comprehensive health ecosystem. It offers personalized wellness plans developed collaboratively by integrative medicine doctors, health coaches, and skilled practitioners. The focus is on whole-person care, enabling members to take an active role in their health through tailored consultations and customized experiences. By combining modern medical insights with traditional healing wisdom, THE WELL empowers its community to maintain their health and well-being effectively.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.